Gene · 2303
Papers2,402
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,402
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells. | Front Oncol | 2023 | 37342194 | PubTator, text mining | PubMed |
| Emerging roles of circ_NRIP1 in tumor development and cancer therapy (Review). | Oncol Lett | 2023 | 37332333 | PubTator, text mining | PubMed |
| Vital roles of m5C RNA modification in cancer and immune cell biology. | Front Immunol | 2023 | 37325635 | PubTator, text mining | PubMed |
| lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma. | Front Mol Biosci | 2023 | 37325482 | PubTator, text mining | PubMed |
| 5-Methylcytosine-related lncRNAs: predicting prognosis and identifying hot and cold tumor subtypes in head and neck squamous cell carcinoma. | World J Surg Oncol | 2023 | 37312123 | PubTator, text mining | PubMed |
| RNAseq profiling of blood from patients with coronary artery disease: Signature of a T cell imbalance. | J Mol Cell Cardiol Plus | 2023 | 37303712 | PubTator, text mining | PubMed |
| Preconditioned Chorionic Villus Mesenchymal Stem/Stromal Cells (CVMSCs) Minimize the Invasive Phenotypes of Breast Cancer Cell Line MDA231 In Vitro. | Int J Mol Sci | 2023 | 37298519 | PubTator, text mining | PubMed |
| A FOXC2 inhibitor, MC-1-F2, as a therapeutic candidate for targeting EMT in castration-resistant prostate cancer. | Bioorg Med Chem Lett | 2023 | 37290495 | PubTator, text mining | PubMed |
| Mapping the transcriptional landscape of human white and brown adipogenesis using single-nuclei RNA-seq. | Mol Metab | 2023 | 37286033 | PubTator, text mining | PubMed |
| Circulating tumour cells for early detection of clinically relevant cancer. | Nat Rev Clin Oncol | 2023 | 37268719 | PubTator, text mining | PubMed |
| Recent Advances in Therapeutic Modalities Against Breast Cancer-Related Lymphedema: Future Epigenetic Landscape. | Lymphat Res Biol | 2023 | 37267206 | PubTator, text mining | PubMed |
| Biomechanical control of lymphatic vessel physiology and functions. | Cell Mol Immunol | 2023 | 37264249 | PubTator, text mining | PubMed |
| Current Concepts in the Management of Primary Lymphedema. | Medicina (Kaunas) | 2023 | 37241126 | PubTator, text mining | PubMed |
| Immunopathology of Extracellular Vesicles in Macrophage and Glioma Cross-Talk. | J Clin Med | 2023 | 37240536 | PubTator, text mining | PubMed |
| Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial-Mesenchymal Transition. | Int J Mol Sci | 2023 | 37239838 | PubTator, text mining | PubMed |
| FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases. | Biomolecules | 2023 | 37238726 | PubTator, text mining | PubMed |
| CDH4 inhibits ferroptosis in oral squamous cell carcinoma cells. | BMC Oral Health | 2023 | 37237299 | PubTator, text mining | PubMed |
| Lymphatic contractile dysfunction in mouse models of Cantú Syndrome with KATP channel gain-of-function. | Function (Oxf) | 2023 | 37214333 | PubTator, text mining | PubMed |
| Molecular genetics of primary open-angle glaucoma. | Indian J Ophthalmol | 2023 | 37203025 | PubTator, text mining | PubMed |
| Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases. | Cell Death Discov | 2023 | 37202385 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2303/papers?page=13